Wellcome Trust Sanger Institute

The Wellcome Trust Sanger Institute was formed in 1992 for the purposes of funding biomedical research. Specifically genome sequencing efforts. It is the largest charity in the U.K., and receives a majority of its funds from the Wellcome Trust. The Institute is responsible for the completion of the sequencing of approximately 1/3 of the human genome and model genomes of the mouse and zebrafish and more than 90 pathogen genomes. Today, the Wellcome Trust Sanger Institute has been able to attract top scientists and has more than 30 Senior Researchers on staff. The Institute is located in Hinxton, Cambridge, U.K., and spends approximately 650 British Pounds annually to support relevant research by preeminent scientists and labs around the globe. The Institute supports work at the University of Nottingham, MIT, University of Toronto, University of Gothenburg, University of Manchester and other institutions of higher learning research labs.

Address
Hinxton, Cambs, CB10 1SA, UK
Website
http://www.sanger.ac.uk/
Wikipedia
http://en.wikipedia.org/wiki/Wellcome_Trust_Sanger_Institute

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Medical research

First lung map uncovers new insights into asthma

For the first time, researchers have mapped the building blocks of the human lungs and airways, in both asthma patients and normal people. The research from the Wellcome Sanger Institute, University Medical Center Groningen, ...

Oncology & Cancer

New cancer drug targets accelerate path to precision medicine

In one of the largest studies of its kind, researchers used CRISPR technology to disrupt every gene in over 300 cancer models from 30 cancer types and discover thousands of key genes essential for cancer's survival. The team, ...

Oncology & Cancer

11,000-year-old living dog cancer reveals its secrets

Scientists have sequenced the genome of the world's oldest continuously surviving cancer, a transmissible genital cancer that affects dogs. This cancer, which causes grotesque genital tumours in dogs around the world, first ...

Genetics

Final chapter to 60-year-old blood group mystery

Researchers have solved a 60-year-old mystery by identifying a gene that can cause rejection, kidney failure and even death in some blood transfusion patients. In this study, published in Nature Genetics online 7 April, they ...

Medical research

Drug screens and CRISPR combine to help make better cancer drugs

A new study has created the most comprehensive analysis for understanding how cancer drugs work at a molecular level. Scientists at the Wellcome Sanger Institute, EMBL's European Bioinformatics Institute (EMBL-EBI) and AstraZeneca ...

page 1 from 28